Solid Biosciences Inc. — Director's Dealing 2021

Jan 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-01-27

Reporting Person: Schneider Joel Solomon Zev (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-27	Common Stock	M	11500	—	Acquired	295615	Direct
2021-01-28	Common Stock	S	3443	$6.1415	Disposed	292172	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-27	Restricted Stock Units	$	M	11500	Disposed		Common Stock (11500)	Direct

Footnotes

F1: Restricted Stock units convert into common stock on a one-for-one basis.

F2: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.

F3: On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date